Prognostic Value of Innate and Adaptive Immunity in Cancers

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Cancer Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-3-662-44006-3_15
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Dysfunction of antigen processing and presentation by dendritic cells in cancer.

  2019cited by this paper
• Protumor Steering of Cancer Inflammation by p50 NF-κB Enhances Colorectal Cancer Progression

  2018cited by this paper
• Contribution of APCs to mucosal-associated invariant T cell activation in infectious disease and cancer

  2018cited by this paper
• Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment

  2018cited by this paper
• The possibility of cancer immune editing in gliomas. A critical review

  2018cited by this paper
• Modeling small cell lung cancer (SCLC) biology through deterministic and stochastic mathematical models

  2018cited by this paper
• Prognostic roles of tumor associated macrophages in bladder cancer: a system review and meta-analysis

  2018cited by this paper
• TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor CD274 (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas

  2018cited by this paper
• Cancer: the dark side of wound healing

  2018cited by this paper
• Hypoxic Signalling in Tumour Stroma

  2018cited by this paper
• Cancer‐related circulating and tumor‐associated neutrophils – subtypes, sources and function

  2018cited by this paper
• Transcriptional Regulation of Macrophages Polarization by MicroRNAs

  2018cited by this paper
• The Role of Macrophage/B-Cell Interactions in the Pathophysiology of B-Cell Lymphomas

  2018cited by this paper
• A complex systems approach to cancer prevention.

  2018cited by this paper
• Evolving notions on immune response in colorectal cancer and their implications for biomarker development

  2018cited by this paper
• Neutrophil heterogeneity: Bona fide subsets or polarization states?

  2018cited by this paper
• Role of nonresolving inflammation in hepatocellular carcinoma development and progression

  2018cited by this paper
• Liver macrophages: Friend or foe during hepatitis B infection?

  2018cited by this paper
• International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.

  2018cited by this paper
• Prognostic significance of immune cells in non-small cell lung cancer: meta-analysis

  2018cited by this paper
• Immunological Approaches Towards Cancer and Inflammation: A Cross Talk

  2018cited by this paper
• Foxp3+ T Regulatory Cells: Still Many Unanswered Questions—A Perspective After 20 Years of Study

  2018cited by this paper
• Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy

  2018cited by this paper
• Epigenetic control of macrophage polarization: implications for targeting tumor-associated macrophages

  2018cited by this paper
• An Emergence Framework of Carcinogenesis

  2017cited by this paper
• Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer

  2017cited by this paper
• The expanding role of innate lymphoid cells and their T-cell counterparts in gastrointestinal cancers.

  2017cited by this paper
• Local Immunotherapy of Cancer: Innovative Approaches to Harnessing Tumor-Specific Immune Responses.

  2017cited by this paper
• Occurrence and significance of tumor‐associated neutrophils in patients with colorectal cancer

  2016cited by this paper
• The immune system and inflammation in breast cancer.

  2014cited by this paper
• Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy

  2013cited by this paper
• Cells, tissues, and organs on chips: challenges and opportunities for the cancer tumor microenvironment.

  2013cited by this paper
• Immune classification of colorectal cancer patients: impressive but how complete?

  2013cited by this paper
• Cellular heterogeneity and molecular evolution in cancer.

  2013cited by this paper
• Neutrophil-mediated tumour angiogenesis: subversion of immune responses to promote tumour growth.

  2013cited by this paper
• Recruitment of monocytes/macrophages in different tumor microenvironments.

  2013cited by this paper
• Fibroblasts as architects of cancer pathogenesis.

  2013cited by this paper
• The gastrointestinal tumor microenvironment.

  2013cited by this paper
• Neutrophils in innate and adaptive immunity

  2013cited by this paper
• Myeloid‐derived suppressor cells in cancer: recent progress and prospects

  2013cited by this paper
• The Tumor Microenvironment: A Pitch for Multiple Players

  2013cited by this paper
• Immunosuppressive Mechanisms of Regulatory Dendritic Cells in Cancer

  2013cited by this paper
• The Immune Microenvironment of Human Tumors: General Significance and Clinical Impact

  2013cited by this paper
• Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer

  2013cited by this paper
• Inflammation and liver tumorigenesis

  2013cited by this paper
• M2-polarized tumor-associated macrophages promoted epithelial–mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway

  2013cited by this paper
• Mast Cells as a Potential Prognostic Marker in Prostate Cancer

  2013cited by this paper
• Role of inflammasomes and their regulators in prostate cancer initiation, progression and metastasis

  2013cited by this paper
• B cells and their mediators as targets for therapy in solid tumors.

  2013cited by this paper
• The Tumor Microenvironment and Strategies to Improve Drug Distribution

  2013cited by this paper
• Cancer systems biology in the genome sequencing era: part 2, evolutionary dynamics of tumor clonal networks and drug resistance.

  2013cited by this paper
• The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment

  2013cited by this paper
• Microenvironment and tumor cell plasticity: an easy way out.

  2013cited by this paper
• Macrophage regulation of tumor responses to anticancer therapies.

  2013cited by this paper
• Targeted cancer immunotherapy.

  2013cited by this paper
• Inflammation Induced by MMP-9 Enhances Tumor Regression of Experimental Breast Cancer

  2013cited by this paper
• Natural killer cells regulate diverse T cell responses.

  2013cited by this paper
• Natural killer cells: walking three paths down memory lane.

  2013cited by this paper
• Carcinoma‐associated fibroblasts: Non‐neoplastic tumour‐promoting mesenchymal cells

  2013cited by this paper
• Memory T cell subsets, migration patterns, and tissue residence.

  2013cited by this paper
• Role of C‐reactive protein in urological cancers: A useful biomarker for predicting outcomes

  2013cited by this paper
• Creation of a suppressive microenvironment by macrophages and cancer-associated fibroblasts.

  2013cited by this paper
• Tumor associated macrophages and neutrophils in tumor progression

  2013cited by this paper
• Cancer cell metabolism: one hallmark, many faces.

  2012cited by this paper
• Systems biology of tumor dormancy: linking biology and mathematics on multiple scales to improve cancer therapy.

  2012cited by this paper
• FOXP3+ cell density in lymphoid follicles from histologically normal mucosa is a strong prognostic factor in early stage colon cancer

  2012cited by this paper
• Inflammasomes as molecular mediators of inflammation and cancer: potential role in melanoma.

  2012cited by this paper
• The emerging role of T cell cytokines in non-small cell lung cancer.

  2012cited by this paper
• Macrophage plasticity and polarization: in vivo veritas.

  2012cited by this paper
• Tobacco, inflammation, and respiratory tract cancer.

  2012cited by this paper
• Inflammation and ovarian cancer.

  2012cited by this paper
• The Distribution of Macrophages with a M1 or M2 Phenotype in Relation to Prognosis and the Molecular Characteristics of Colorectal Cancer

  2012cited by this paper
• Tumor-associated neutrophils: friend or foe?

  2012cited by this paper
• Cancer classification using the Immunoscore: a worldwide task force

  2012cited by this paper
• What are regulatory T cells (Treg) regulating in cancer and why?

  2012cited by this paper
• The immune contexture in human tumours: impact on clinical outcome

  2012cited by this paper
• Cancer-Related Inflammation

  2012cited by this paper
• Multiscale Models of Breast Cancer Progression

  2012cited by this paper
• Tertiary Intratumor Lymphoid Tissue in Colo-Rectal Cancer

  2011cited by this paper
• An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer

  2011cited by this paper
• Tumor immunosurveillance in human cancers

  2011cited by this paper
• Biological Computation

  2011cited by this paper
• Extracellular proteolysis in macrophage migration: Losing grip for a breakthrough

  2011cited by this paper
• Cancer‐promoting tumor‐associated macrophages: New vistas and open questions

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.

  2011cited by this paper
• Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.

  2011cited by this paper
• Neutrophils in the activation and regulation of innate and adaptive immunity

  2011cited by this paper
• CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans

  2011cited by this paper
• High frequency of tumor‐infiltrating FOXP3+ regulatory T cells predicts improved survival in mismatch repair‐proficient colorectal cancer patients

  2010cited by this paper
• Immune infiltration in human tumors: a prognostic factor that should not be ignored

  2010cited by this paper
• Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.

  2010cited by this paper
• CD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes

  2010cited by this paper
• The role of the tissue microenvironment in the regulation of cancer cell motility and invasion

  2010cited by this paper
• Tumor-Conditioned Macrophages Secrete Migration-Stimulating Factor: A New Marker for M2-Polarization, Influencing Tumor Cell Motility

  2010cited by this paper
• Multiscale cancer modeling.

  2010cited by this paper
• Inflammation and colon cancer.

  2010cited by this paper
• Tumour‐infiltrating T‐cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review

  2010cited by this paper
• Immunity, inflammation, and cancer.

  2010cited by this paper
• The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer

  2010cited by this paper

• Different Behavioral Patterns of SARS-COV-2 in Patients with Various Types of Cancers: A Role for Chronic Inflammation Induced by Macrophages

  2021cites this paper
• miRNAs in the Regulation of Cancer Immune Response: Effect of miRNAs on Cancer Immunotherapy

  2021cites this paper
• Different Behavioral Patterns of SARS-COV-2 in Patients with Various Types of Cancers: A Role for Chronic In ammation Induced by Macrophages

  2021cites this paper
• The role of mouse models in colorectal cancer research—The need and the importance of the orthotopic models

  2020cites this paper
• De novo colorectal cancer after liver and kidney transplantation–Microenvironment disturbance

  2020cites this paper